2026
HYBRID
14 - 16 SEPTEMBER 2026
BLED, SLOVENIA

MSS2026 Speakers

Dan Peer

Dan Peer

Laboratory of Precision Nanomedicine, Tel Aviv University

The RNA revolution: from novel vaccines to therapeutic genome editing

Andre Germishuizen

Andre Germishuizen

National Bioproducts Institute (NBI)

Commercial-Scale Evaluation of a CIMmultus® Mixed-Mode Monolith for IgG Production

Jacek Lubelski

Jacek Lubelski

NanoCell

tLNP as a Novel Gene Therapy Vector to Deliver DNA

Aleš Štrancar

Aleš Štrancar

BIA Separations Inc

Beyond the Cohn Process: Novel Approaches to Overcome Bottlenecks in Plasma Fractionation

Manuela Bartolini

Manuela Bartolini

Alma Mater Studiorum University of Bologna

Monolith-based Immobilized Enzyme Reactors: Enabling Technologies for Diverse and Evolving Landscapes

Stefano Menegatti

Stefano Menegatti

North Carolina State University

Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies

Thomas Muster

Thomas Muster

BlueSky Immunotherapies

Interferon-inducing viral vector immunotherapy reprograms tumor immunity and eliminates persistent HPV infection

BE PART OF MSS2026

REGISTER

MSS2026 is about Bridging Science, Innovation and Manufacturing in Bioprocessing and Biopharma. Will you be part of it?

REGISTER HERE

CONNECT WITH US

Help us grow a LinkedIn community of experts working in gene therapies, vaccines, and other biological products. Get event updates, special offers, discounts, and more.

MSS2024 OVERVIEW

Take a look at previous editions and hear what past participants had to say.

GET A MSS2024 OVERVIEW
HIGHLIGHTS

PREVIOUS EVENT HIGHLIGHTS

HEAR FROM PAST ATTENDEES
[email protected]